Skip to main content
Premium Trial:

Request an Annual Quote

Devgen in RNAi Collaboration with Genentech

NEW YORK, June 2 - Devgen has completed a research collaboration with Genentech using RNAi in C. elegans to elucidate the role of genes in cellular pathways related to cancer, the company said today.

 

Devgen, of Ghent, Belgium, has created a genome-wide library of RNA interference sequence to suppress the activity of of the 19,000 C. elegans genes. Devgen plans to use the library in drug-target identification and functional validation. It uses the RNAi along with its Function Factory, a database that includes the phenotypic profiles of C. elegans mutants as well as the effect of gene knockdowns, drugs, and other compounds on the mutants.

 

The parties did not disclose the financial terms of the agreement.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.